1. Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress. Bansal S, Liu CP, Sepuri NB, Anandatheerthavarada HK, Selvaraj V, Hoek J, Milne GL, Guengerich FP, Avadhani NG (2010) J Biol Chem 285(32): 24609-19
    › Primary publication · 20529841 (PubMed) · PMC2915697 (PubMed Central)
  2. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Wu X, Cai H, Xiang YB, Cai Q, Yang G, Liu D, Sanchez S, Zheng W, Milne G, Shu XO (2010) Cancer Epidemiol Biomarkers Prev 19(4): 947-52
    › Primary publication · 20332256 (PubMed) · PMC2874066 (PubMed Central)
  3. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Rho YH, Chung CP, Oeser A, Solus JF, Gebretsadik T, Shintani A, Raggi P, Milne GL, Stein CM (2010) Arthritis Care Res (Hoboken) 62(10): 1473-80
    › Primary publication · 20506360 (PubMed) · PMC2933413 (PubMed Central)
  4. Increased oxidative stress and altered substrate metabolism in obese children. Oliver SR, Rosa JS, Milne GL, Pontello AM, Borntrager HL, Heydari S, Galassetti PR (2010) Int J Pediatr Obes 5(5): 436-44
    › Primary publication · 20233149 (PubMed) · PMC3110748 (PubMed Central)
  5. Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. Brown JE, Zeiger SL, Hettinger JC, Brooks JD, Holt B, Morrow JD, Musiek ES, Milne G, McLaughlin B (2010) J Neurosci 30(15): 5242-52
    › Primary publication · 20392947 (PubMed) · PMC2869196 (PubMed Central)
  6. Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. Montine TJ, Sonnen JA, Milne G, Baker LD, Breitner JC (2010) PLoS One 5(2): e9340
    › Primary publication · 20174466 (PubMed) · PMC2824826 (PubMed Central)
  7. Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. Norman KG, Canter JA, Shi M, Milne GL, Morrow JD, Sligh JE (2010) Mitochondrion 10(2): 94-101
    › Primary publication · 19836469 (PubMed) · PMC6917037 (PubMed Central)
  8. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study. Dong LM, Shu XO, Gao YT, Milne G, Ji BT, Yang G, Li HL, Rothman N, Zheng W, Chow WH, Abnet CC (2009) Cancer Epidemiol Biomarkers Prev 18(11): 3075-8
    › Primary publication · 19861525 (PubMed) · PMC2783404 (PubMed Central)
  9. Two pathways for cyclooxygenase-2 protein degradation in vivo. Wada M, Saunders TL, Morrow J, Milne GL, Walker KP, Dey SK, Brock TG, Opp MR, Aronoff DM, Smith WL (2009) J Biol Chem 284(45): 30742-53
    › Primary publication · 19758985 (PubMed) · PMC2781473 (PubMed Central)
  10. The enteropathy of prostaglandin deficiency. Adler DH, Phillips JA, Cogan JD, Iverson TM, Schnetz-Boutaud N, Stein JA, Brenner DA, Milne GL, Morrow JD, Boutaud O, Oates JA (2009) J Gastroenterol : 1-7
    › Primary publication · 19148786 (PubMed) · PMC2799331 (PubMed Central)